Overcoming Chemotherapy Resistance in SCLC
2021
Abstract SCLC is an aggressive form of lung cancer with a very poor prognosis. Although SCLC initially responds very well to platinum-based chemotherapy, it eventually recurs and at recurrence is nearly universally resistant to therapy. In light of the recent advances in understanding regarding the biology of SCLC, we review findings related to SCLC chemotherapy resistance. We discuss the potential clinical implications of recent preclinical discoveries in altered signaling pathways, transcriptional landscapes, metabolic vulnerabilities, and the tumor microenvironment.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
102
References
0
Citations
NaN
KQI